Trial intelligence / Profile preview

Sativex Long-term Safety in Cancer Pain

NCT00675948Phase 3Completed

Sponsor
Jazz Pharmaceuticals plc
Start
Apr 2002
Primary completion
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of cannabis extract in cancer pain, sponsored by Jazz Pharmaceuticals plc. Started Apr 2002; status: completed.

02

Drugs

cannabis extract
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT00675948.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00675948.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call